Similar articles

• [Brain functional imaging in Alzheimer's disease].

  Ravasi L, Semah F. Ravasi L, et al. Psychol Neuropsychiatr Vieil. 2009 Dec;7 Spec No 1:21-7. doi: 10.1684/pnv.2009.0193. Psychol Neuropsychiatr Vieil. 2009. PMID: 20061230 Review. French.
• Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's disease.

  Chételat G, Villemagne VL, Pike KE, Ellis KA, Bourgeat P, Jones G, O'Keefe GJ, Salvado O, Szoeke C, Martins RN, Ames D, Masters CL, Rowe CC; Australian Imaging Biomarkers and Lifestyle Study of ageing (AIBL) Research Group. Chételat G, et al. Brain. 2011 Mar;134(Pt 3):798-807. doi: 10.1093/brain/awq383. Epub 2011 Feb 9. Brain. 2011. PMID: 21310725
• Technology Insight: imaging amyloid plaques in the living brain with positron emission tomography and MRI.

  Huddleston DE, Small SA. Huddleston DE, et al. Nat Clin Pract Neurol. 2005 Dec;1(2):96-105. doi: 10.1038/ncpneuro0046. Nat Clin Pract Neurol. 2005. PMID: 16932505 Review.
• Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement.

  Ossenkoppele R, Zwan MD, Tolboom N, van Assema DM, Adriaanse SF, Kloet RW, Boellaard R, Windhorst AD, Barkhof F, Lammertsma AA, Scheltens P, van der Flier WM, van Berckel BN. Ossenkoppele R, et al. Brain. 2012 Jul;135(Pt 7):2115-25. doi: 10.1093/brain/aws113. Epub 2012 May 3. Brain. 2012. PMID: 22556189
• Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy.

  Tateno A, Sakayori T, Kawashima Y, Higuchi M, Suhara T, Mizumura S, Mintun MA, Skovronsky DM, Honjo K, Ishihara K, Kumita S, Suzuki H, Okubo Y. Tateno A, et al. Int J Geriatr Psychiatry. 2015 May;30(5):505-13. doi: 10.1002/gps.4173. Epub 2014 Jul 7. Int J Geriatr Psychiatry. 2015. PMID: 25043833